No, domperidone does not help with dizziness from acute vestibular causes
Domperidone is a gastrointestinal prokinetic agent designed to treat nausea and vomiting from gastroparesis—it has no role in treating vertigo or dizziness from vestibular disorders. In your patient presenting with acute dizziness, fever, headache, and sore throat, domperidone would be inappropriate and ineffective.
Why Domperidone Is Not Indicated
Mechanism of Action
Domperidone is a peripheral D2 dopamine receptor antagonist that works primarily in the upper gastrointestinal tract 1. It does not readily cross the blood-brain barrier 1, which means it lacks central vestibular suppressant effects. The drug's therapeutic benefits are limited to:
- Improving gastric motility through prokinetic effects 2
- Reducing nausea and vomiting associated with gastroparesis 2
- No direct antiemetic effect on the vestibular system 2
Evidence Against Use in Vertigo
The available guidelines explicitly address medications for acute vertigo and do not include domperidone. The 2008 BPPV Clinical Practice Guideline recommends against routine use of vestibular suppressant medications for vertigo 3. While this guideline specifically discusses antihistamines and benzodiazepines, the principle applies: medications should target the underlying vestibular pathophysiology, which domperidone does not address.
A 2022 meta-analysis of 1,586 patients with acute vertigo found that antihistamines provided modest benefit at 2 hours compared to benzodiazepines, but neither class showed superiority to placebo at 1 week or 1 month 4. Notably, domperidone was not studied or recommended for vertigo treatment in this comprehensive review.
What Actually Works for Acute Dizziness
For Vestibular Causes
- Antihistamines (meclizine, diphenhydramine) may provide short-term symptom relief for the spinning sensation 3
- Benzodiazepines (diazepam, clonazepam) can reduce subjective spinning but interfere with central compensation 3
- Critical caveat: Both classes should only be used briefly for severe symptoms, as they can delay vestibular compensation and prolong recovery 3
For Your Specific Patient
Given the constellation of fever, headache, and sore throat with dizziness, consider:
- Vestibular neuritis (viral infection of vestibular system) - presents with acute prolonged vertigo lasting 12-36 hours without hearing loss 5
- Labyrinthitis (if hearing loss present) - sudden severe vertigo with profound hearing loss 5
- Central causes requiring urgent evaluation if neurologic signs present
Important Clinical Pitfalls
Domperidone-Specific Concerns
Even if domperidone were considered for nausea alone (which would be off-label for acute vestibular causes):
- Not FDA-approved in the United States for human use 2
- Requires expanded access IND application 2
- Current US supplier is exiting the market 2
- Requires baseline ECG, potassium, and magnesium monitoring due to QTc prolongation risk 2
- Common side effects include palpitations, chest pain, dizziness (ironically), and headache 6
Medication Selection Error
Prescribing domperidone for dizziness represents a fundamental misunderstanding of the drug's indication. The 2025 AGA Gastroparesis Guidelines clearly state domperidone is suggested against as first-line treatment even for gastroparesis (conditional recommendation, very low quality evidence) 2. Its use is reserved for patients with gastroparesis who have failed or cannot tolerate metoclopramide 2.
Appropriate Management Algorithm
Determine timing and triggers: Is this acute vestibular syndrome (continuous days), triggered episodic (seconds with position change), or spontaneous episodic (minutes to hours)? 7, 8
Assess for red flags: Neurologic deficits, severe headache, inability to walk, or abnormal HINTS exam suggest central cause requiring urgent imaging 8
For peripheral vestibular causes without red flags:
Reassess within 1 month to confirm symptom resolution and diagnostic accuracy 3
Bottom line: Domperidone has zero role in treating dizziness from vestibular causes. It is a gastroparesis medication with significant cardiac risks, limited availability, and no mechanism of action relevant to vertigo. Your patient needs appropriate vestibular evaluation and, if necessary, brief vestibular suppressants—not a prokinetic agent.